REFERENCES
- Frank S, Durovic S, Kostner GM. The assembly of lipoprotein Lp(a). Eur J Clin Invest 1996; 26: 109 — 14.
- Hobbs HH, White AL. Lipoprotein(a): intrigues and insights. CUff Opin Lipidol 1999; 10: 225–36.
- Dieplinger H, Utermann G. The seventh myth of lipoprotein(a): where and how is it assembled? Curr Opin Lipidol 1999; 10: 275–83.
- Craig WY, Neveux LM, Palomaki GE, Cleveland MM, Haddow JE. Lipoprotein(a) as a risk factor for ischemic heart disease: metaanalysis of pros-pective studies. Clin Chem 1998; 44: 2301–6.
- Boerwinkle E, Leffert CC, Lin J, Lackner C, Chiesa G, Hobbs HH. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J Clin Invest 1992; 90: 52–60.
- Rainwater DL, Haffner SM. Insulin and 2-hour glucose levels are inversely related to Lp(a) concentrations controlled for LPA genotype. Arterioscler Thromb Vasc Biol 1998; 18: 1335–41.
- Inoue K, Nago N, Matsuo H, Goto T, Miyamoto T, Saegusa T, Ishikawa S, Kano K, Nakamura Y, Igarashi M. Serum insulin and lipoprotein(a) concentrations. The Jichi medical school cohort study. Diabetes Care 1997; 20: 1242–7.
- Neele DM, Wit de ECM, Princen HMG. Insulin suppresses apolipoprotein(a) synthesis by primary cultures of cynomolgus monkey hepatocytes. Diabetologia 1999; 42: 41–4.
- Riemens SC, Ligtenberg JJM, Dullaart RPF. Hyperglycemia-induced hyperinsulinemia acutely lowers plasma apolipoprotein B but not lipo-protein (a) in man. Clin Chim Acta 1997; 261: 149— 58.
- Rader DJ, Cain W, Zech LA, Usher D, Brewer HB. Variation in lipoprotein(a) concentrations with the same apolipoprotein(a) isoform is deter-mined by the rate of lipoprotein(a) production. J Clin Invest 1993; 91: 443–7.
- Taskinen MR, Packard CJ, Shepherd J. Effect of insulin therapy on metabolic fate of apolipo-protein B-containing lipoproteins in NIDDM. Diabetes 1990; 39: 1017–27.
- Alberti KGMM, Zimmet PZ, for the WHO consultation. Definition, diagnosis and classifica-tion of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consulta-tion. Diabet Med 1998; 15: 539–53.
- Demacker PN, Hijmans AG, Vos-Janssen HE, Van't Laar A, Jansen AP. A study of the use of polyethylene glycol in estimating cholesterol in high-density lipoprotein. Clin Chem 1980; 26: 1775–9.
- Lewis GF, Uffelman KD, Szeto LW, Weller B, Steiner G. Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans. J Clin Invest 1995; 95: 158–66.
- Malmström R, Packard CJ, Watson TDG, Rannikko S, Caslake M, Bedford D, Stewart P, Yki-Järvinen H, Shepherd J, Taskinen MR. Metabolic basis of hypotriglyceridemic effects of insulin in normal men. Arterioscler Thromb Vasc Biol 1997; 17: 1454–64.
- Yki-Järvinen H, Taskinen MR, Koivisto VA, Nikkild EA. Response of adipose tissue lipo-protein lipase activity and serum lipoproteins to acute hyperinsulinaemia in man. Diabetologia 1984; 27: 364–9.
- Krempler F, Kostner G, Bolzano K, Sandhofer F. Lipoprotein(a) is not a metabolic product of other lipoproteins containing apolipoprotein B. Biochim Biophys Acta 1979; 575: 63–70.
- Nassir F, Bonen DK, Davidson NO. Apolipo-protein(a) synthesis and secretion from hepatoma cells is coupled to triglyceride synthesis and secretion. J Biol Chem 1998; 273: 17793–800.
- Edelstein C, Davidson NO, Scanu AM. Oleate stimulates the formation of triglyceride-rich particles containing apoB100-apo(a) in long-term primary cultures of human hepatocytes. Chem Phys Lipids 1994; 67/68: 135–43.
- Su W, Campos H, Judge H, Walsh BW, Sachs FM. Metabolism of apo(a) and apoB100 of lipoprotein(a) in women: effect of postmenopausal estrogen replacement. J Clin Endocrinol Metab 1998; 83: 3267–76.